Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

4/18/23 md Duplicate Anticoagulant Alert Trial
April 18, 2023

From: "Mary Dang" <mary.dang@hhsys.org>
To: "Pharmacists" <grp_allpharm@hhsys.org>
Sent: Tuesday, April 18, 2023 11:01:36 AM
Subject: Duplicate Anticoagulant Alert Trial

Hello,

Just a reminder that the duplicate anticoagulant alert started today. Please see below:

The duplicate therapy checking was going to be implemented in Cerner. Currently, duplicate therapy checking is turned on for ACTIVE enoxaparin and apixaban orders only. However, in this event, the duplicate dose was from an INACTIVE one time enoxaparin order. We will be adjusting the setting for Discontinue Days/Include in alerts to 1 day for enoxaparin on 4/17 and 4/18. This means that an INACTIVE order that has been discontinued less than 1 day will generate a duplicate alert. We are concerned that this will significantly increase the number of false positive alerts and contribute to alert fatigue so we will be turning this on for those 2 days only and then evaluating data to assess the utility of this setting.

 

Let's see what this does....if effective or not. 

 






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved